期刊文献+

依托泊苷微乳相图的研究 被引量:4

Phase diagram of etoposide microemulsion
下载PDF
导出
摘要 目的确定o/w型依托泊苷微乳处方。方法选用油酸、十四酸异丙酯和十六酸异丙酯作为油相,Tween80、Cremophor EL和Cremophor RH40作为表面活性剂,乙醇、1,2-丙二醇、异丙醇、甘油和PEG 400为助表面活性剂,通过滴定法绘制伪三元相图,以o/w型微乳区大小为指标筛选处方。结果确定了最终空白微乳处方为Cremophor RH40∶乙醇∶PEG 400∶水∶十四酸异丙酯=19.0∶19.0∶19.0∶38.2∶4.8(w/w)。结论所选择的微乳处方可以满足依托泊苷载药量的要求。 Objective To develop the o/w etoposide microemulsion formulation. Methods Oleic acid, isopropyl myristate and isopropyl palmitate were chosen for oils. Tween 80 , Cremophor EL and Cremophor RH40 were selected as surfactants. Ethanol, isopropyl alcohol, 1, 2-propylene glycol, glycerin and PEG 400 were used as cosurfactants. The pseudotertiary phase diagrams were obtained by titration. The formulation was screened by the o/w microemulsion area. Results The final blank microemulsion formulation was: cremophor RH40 : ethanol : PEG 400 : isopropyl miristate : water=19.0 : 19.0 : 19.0 : 38.2 : 4.8. Conclusion The defined microemulsion formulation can be used to carry etoposide.
出处 《中南药学》 CAS 2008年第5期516-519,共4页 Central South Pharmacy
基金 "国家科技支撑计划"子课题 新型载体给药系统及其成药性综合评价关键技术与应用研究(项目编号:2007BAI41B05)
关键词 微乳 依托泊苷 伪三元相图 microemulsion etoposide pseudoternary phase diagram
  • 相关文献

参考文献8

  • 1[1]Aisner J,Lee EJ,Etoposide.Current and future status[J].Cancer,1991,67(supple 1):215-219.
  • 2[2]Katoh O,Yamada H,Hiura K Clinical pharmacology and toxicity of low daily administration of oral etoposide in advanced lung cancer patients[J].J Clin Pharmacol,1991,31(12):1155-1160.
  • 3[3]Gao ZG,Choi HG,Shin HJ,et al.Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporin A[J].Int J Pharm,1998,161(1):75-86.
  • 4刘霞,向大雄.o/w型、w/o型葛根素口服微乳的制备及质量评价[J].中南药学,2007,5(5):451-455. 被引量:11
  • 5王晓黎,蒋雪涛,李干佐,牟建海.非离子型表面活性剂微乳的基础研究[J].解放军药学学报,2001,17(6):297-300. 被引量:27
  • 6[6]Park ES,Cui Y,Yun BJ,et al.Transdermal delivery of piroxicam using microemulsions[J],Arch Pharm Res,2005,28(2):243-250.
  • 7尹东东,王杏林,赵广荣,李萌.依托泊苷微乳的HPLC测定[J].中国医药工业杂志,2007,38(2):121-122. 被引量:16
  • 8[8]Comelles F,Sanchez Leal J.Oleic acid/glycol:an alternative to pentanol in microemulslons with anionic surfactant[J].J Dispersion Science and Technology,1998,19(4):521-533.

二级参考文献16

  • 1姚静,周建平,杨宇欣,平其能.微乳对难溶性药物增溶机理的研究[J].中国药科大学学报,2004,35(6):495-498. 被引量:28
  • 2郭荣,王秀文,李干佐.微乳液的微观结构与稳定理论(第二讲)[J].日用化学工业,1989,19(6):44-49. 被引量:13
  • 3崔晶,翟光喜,娄红祥.姜黄素微乳的研制及其性质研究[J].中国药学杂志,2005,40(24):1877-1880. 被引量:27
  • 4[4]Kim CK,Cho YJ,Gao ZG.Preparation and evaluation of biphenyl dimethyl dicarboxylate microemulsions for oral delivery[J].Journal of Controlled Release,2001,70(12):149-155.
  • 5[5]Kang BK,Lee JS,Chon SK,et al.Development of self-microemulsifying drug delivery systems(SMEDDS)for oral bioavailability enhancement of simvastatinin beagle dogs[J].Intematiohal Journal of Pharmaceutics,2004,274(12):65-73.
  • 6[6]Kohsaku Kawakami,Takayoshi Yoshikawa,Yasushi Moroto,et al.Microemulsion formulation for enhanced absorption of poorly soluble drugs I[J].Prescription design Journal of Controlled Release,2002,81(2):65-74.
  • 7[10]René Holm,Anette Mǖllertz,Egon Christensen,et al.Comparison of total oral bioavailability and the lymphatic transport of halofantrine from three different unsaturated tfiglycerides in lymph-cannulated conscious rats[J].European Journal of Pharmaceutical Sciences,2001(14):331-337.
  • 8[11]Kazunori I,Toshihiro K,Makoto M,et al.Disposition of Lipid-Based Formulation in the Intestinal Tract Affects the Absorption of Poorly Water-Soluble Drugs[J].Biol Pharm Bull,2006,29(3):508-512.
  • 9[12]DAVID J.HAUSS,STEVEN E.FOGAL Lipid-Based Delivery Systems for Improving the Bioavailability and Lymphatic Transport of a Poorly Water-Soluble LTIM Inhibitor[J].Journal of Pharmaceutical Sciences,1998,87(2):165-169.
  • 10Gao ZG, Choi HG, Shin HJ, et al. Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporin A[J]. Int J Pharm, 1998,161(1): 75-86.

共引文献51

同被引文献45

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部